BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18449811)

  • 1. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.
    Markovic O; Marisavljevic D; Cemerikic V; Suvajdzic N; Milic N; Colovic M
    Med Oncol; 2004; 21(1):73-80. PubMed ID: 15034217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
    Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
    Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
    Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
    Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
    Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
    Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
    Himani B; Meera S; Abhimanyu S; Usha R
    Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.
    Munshi NC; Wilson C
    Semin Oncol; 2001 Dec; 28(6):565-9. PubMed ID: 11740810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.
    Babarović E; Valković T; Štifter S; Budisavljević I; Seili-Bekafigo I; Duletić-Načinović A; Lučin K; Jonjić N
    Am J Clin Pathol; 2012 Jun; 137(6):870-8. PubMed ID: 22586045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
    Rana C; Sharma S; Agrawal V; Singh U
    Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.
    Sezer O; Niemöller K; Eucker J; Jakob C; Kaufmann O; Zavrski I; Dietel M; Possinger K
    Ann Hematol; 2000 Oct; 79(10):574-7. PubMed ID: 11100749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bone marrow angiogenesis in multiple myeloma.
    Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
    Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of WT1 and VEGF Expression with Angiogenesis in Bone Marrow Biopsies of Multiple Myeloma Patients].
    Li GJ; Ding H; Yang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):733-6. PubMed ID: 26117027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferative activity of myeloma cells determined by Ki-67 antibody: biological and clinical significance].
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Bakrac M; Perunicić M; Suvajdzić N; Colović M
    Vojnosanit Pregl; 2005 Jan; 62(1):33-8. PubMed ID: 15715347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.